180 related articles for article (PubMed ID: 23108300)
21. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
Koike K
Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus and hepatocellular carcinoma.
Colombo M
Semin Liver Dis; 1999; 19(3):263-9. PubMed ID: 10518306
[TBL] [Abstract][Full Text] [Related]
23. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
[TBL] [Abstract][Full Text] [Related]
24. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
25. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
28. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.
Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U
Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360
[TBL] [Abstract][Full Text] [Related]
30. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
Castello G; Scala S; Palmieri G; Curley SA; Izzo F
Clin Immunol; 2010 Mar; 134(3):237-50. PubMed ID: 19910258
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus related hepatocellular carcinoma: a case control study from India.
Sarma MP; Asim M; Medhi S; Bharathi T; Kar P
J Med Virol; 2012 Jul; 84(7):1009-17. PubMed ID: 22585716
[TBL] [Abstract][Full Text] [Related]
32. Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production.
Khaliq S; Jahan S; Pervaiz A
Infect Genet Evol; 2011 Apr; 11(3):543-56. PubMed ID: 21292033
[TBL] [Abstract][Full Text] [Related]
33. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation.
Shiffman ML
Liver Transpl; 2003 Nov; 9(11):S14-20. PubMed ID: 14586890
[TBL] [Abstract][Full Text] [Related]
34. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
Farinati F; Cardin R; Bortolami M; Burra P; Russo FP; Rugge M; Guido M; Sergio A; Naccarato R
J Viral Hepat; 2007 Dec; 14(12):821-9. PubMed ID: 18070284
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
37. The changing epidemiology and natural history of hepatitis C virus infection.
Bialek SR; Terrault NA
Clin Liver Dis; 2006 Nov; 10(4):697-715. PubMed ID: 17164113
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
39. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]